miRNA profile in ovarian cancer
Ovarian cancer is a gynecological cancer with high mortality and a heterogeneous nature
which complicates its early detection and primary prevention. Numerous studies have …
which complicates its early detection and primary prevention. Numerous studies have …
[HTML][HTML] New dimension of glucocorticoids in cancer treatment
KT Lin, LH Wang - Steroids, 2016 - Elsevier
Glucocorticoids have been used in clinical oncology for over half a century. The clinical
applications of glucocorticoids in oncology are mainly dependent on their pro-apoptotic …
applications of glucocorticoids in oncology are mainly dependent on their pro-apoptotic …
[HTML][HTML] Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 …
SC Lin, YC Liao, PM Chen, YY Yang, YH Wang… - Journal of Biomedical …, 2022 - Springer
Background Ovarian cancer has the highest mortality among gynecological cancers due to
late diagnosis and lack of effective targeted therapy. Although the study of interplay between …
late diagnosis and lack of effective targeted therapy. Although the study of interplay between …
Ras and Rap1: A tale of two GTPases
S Shah, EJ Brock, K Ji, RR Mattingly - Seminars in cancer biology, 2019 - Elsevier
Ras oncoproteins play pivotal roles in both the development and maintenance of many
tumor types. Unfortunately, these proteins are difficult to directly target using traditional …
tumor types. Unfortunately, these proteins are difficult to directly target using traditional …
[HTML][HTML] Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway
The early onset breast cancer patients (age≤ 40) often display higher incidence of axillary
lymph node metastasis, and poorer five-year survival than the late-onset patients. To identify …
lymph node metastasis, and poorer five-year survival than the late-onset patients. To identify …
[HTML][HTML] 11q deletion in neuroblastoma: a review of biological and clinical implications
V Mlakar, S Jurkovic Mlakar, G Lopez, JM Maris… - Molecular cancer, 2017 - Springer
Deletion of the long arm of chromosome 11 (11q deletion) is one of the most frequent events
that occur during the development of aggressive neuroblastoma. Clinically, 11q deletion is …
that occur during the development of aggressive neuroblastoma. Clinically, 11q deletion is …
[HTML][HTML] Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
Glioma, also known as glioblastoma multiforme (GBM), is the most prevalent and most lethal
primary brain tumor in adults. Gliomas are highly invasive tumors with the highest death rate …
primary brain tumor in adults. Gliomas are highly invasive tumors with the highest death rate …
[HTML][HTML] Notch-induced miR-708 antagonizes satellite cell migration and maintains quiescence
MB Baghdadi, J Firmino, K Soni, B Evano… - Cell stem cell, 2018 - cell.com
Critical features of stem cells include anchoring within a niche and activation upon injury.
Notch signaling maintains skeletal muscle satellite (stem) cell quiescence by inhibiting …
Notch signaling maintains skeletal muscle satellite (stem) cell quiescence by inhibiting …
[HTML][HTML] Impact of glucocorticoid use in oncology in the immunotherapy era
L Kalfeist, L Galland, F Ledys, F Ghiringhelli… - Cells, 2022 - mdpi.com
Thanks to their anti-inflammatory, anti-oedema, and anti-allergy properties, glucocorticoids
are among the most widely prescribed drugs in patients with cancer. The indications for …
are among the most widely prescribed drugs in patients with cancer. The indications for …
[HTML][HTML] The role of Ras-associated protein 1 (Rap1) in cancer: bad actor or good player?
Metastasis is known as the most life-threatening event in cancer patients. In principle, the
immune system can prevent tumor development. However, dysfunctional T cells may fail to …
immune system can prevent tumor development. However, dysfunctional T cells may fail to …